• OPEN AN ACCOUNT
Indian Indices
Sensex
79,310.01 0.00
( 0.00%)
Global Indices
Nasdaq
51,872.69 -1,504.43
(-2.82%)
Dow Jones
7,442.16 -267.46
(-3.47%)
Hang Seng
60,935.13 -1,253.50
(-2.02%)
Nikkei 225
10,776.27 -52.94
(-0.49%)
Forex
USD-INR
94.73 -0.07
(-0.07%)
EUR-INR
105.99 -0.12
(-0.11%)
GBP-INR
127.06 -0.04
(-0.03%)
JPY-INR
0.60 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
36.4616629
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
44.18
14213.48
EPS(TTM)
Face Value()
Div & Yield %
7.1
1
0.29
 

Osiajee Texfab consolidated net profit declines 29.28% in the March 2026 quarter
May 29,2026
Net profit of Osiajee Texfab declined 29.28% to Rs 2.56 crore in the quarter ended March 2026 as against Rs 3.62 crore during the previous quarter ended March 2025. Sales declined 42.80% to Rs 2.78 crore in the quarter ended March 2026 as against Rs 4.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.00% to Rs 5.55 crore in the year ended March 2026 as against Rs 5.00 crore during the previous year ended March 2025. Sales declined 8.46% to Rs 6.49 crore in the year ended March 2026 as against Rs 7.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.784.86 -43 6.497.09 -8
OPM %88.1375.10 -81.6670.66 -
PBDT2.603.66 -29 5.585.04 11
PBT2.563.62 -29 5.555.00 11
NP2.563.62 -29 5.555.00 11